Antony, France

Melanie Heurteau


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Cardiac Resynchronization: The Contributions of Melanie Heurteau

Introduction

Melanie Heurteau is a prominent inventor based in Antony, France. She has made significant contributions to the field of medical devices, particularly in cardiac resynchronization technology. With a total of 2 patents to her name, her work focuses on improving heart function through innovative implantable devices.

Latest Patents

Heurteau's latest patents include an "Implantable Medical Device for Resynchronization by Biventricular Pacing Using Reverse Remodeling." This device is designed to detect atrial and ventricular events and apply electrical pulses to various stimulation sites in the heart. The technology allows for a dynamic change in pacing configurations, enhancing the heart's response to stimulation. Another notable patent is the "Implantable Cardiac Prosthetic for Resynchronization by Biventricular Pacing Using Reverse Remodeling." This invention aims to improve cardiac response metrics such as pressure and ejected volume by utilizing controlled stimulation sequences.

Career Highlights

Melanie Heurteau is associated with Sorin Crm Sas, a company known for its advancements in cardiac devices. Her work has been instrumental in developing technologies that address complex cardiac conditions, showcasing her expertise in the medical device industry.

Collaborations

Heurteau collaborates with Cyrille Casset, contributing to the innovative environment at Sorin Crm Sas. Their partnership exemplifies the collaborative spirit necessary for advancing medical technology.

Conclusion

Melanie Heurteau's contributions to cardiac resynchronization technology highlight her role as a leading inventor in the medical field. Her innovative patents reflect a commitment to improving patient outcomes through advanced medical devices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…